Citation: Mv. Govindan et N. Warriar, RECONSTITUTION OF THE N-TERMINAL TRANSCRIPTION ACTIVATION FUNCTION OFHUMAN MINERALOCORTICOID RECEPTOR IN A DEFECTIVE HUMAN GLUCOCORTICOID RECEPTOR, The Journal of biological chemistry, 273(38), 1998, pp. 24439-24447
Citation: N. Warriar et al., EXPRESSION OF HUMAN GLUCOCORTICOID RECEPTOR GENE AND INTERACTION OF NUCLEAR PROTEINS WITH THE TRANSCRIPTIONAL CONTROL ELEMENT, The Journal of biological chemistry, 271(31), 1996, pp. 18662-18671
Authors:
REYESMORENO C
FRENETTE G
BOULANGER J
LAVERGNE E
GOVINDAN MV
KOUTSILIERIS M
Citation: C. Reyesmoreno et al., MEDIATION OF GLUCOCORTICOID RECEPTOR FUNCTION BY TRANSFORMING GROWTH-FACTOR-BETA-I EXPRESSION IN HUMAN PC-3 PROSTATE-CANCER CELLS, The Prostate, 26(5), 1995, pp. 260-269
Citation: Cy. Yu et al., CYSTEINE-638 AND CYSTEINE-665 IN THE HORMONE-BINDING DOMAIN OF HUMAN GLUCOCORTICOID RECEPTOR DEFINE THE SPECIFICITY TO GLUCOCORTICOIDS, Biochemistry, 34(43), 1995, pp. 14163-14173
Citation: N. Page et al., 11-BETA-HYDROXYSTEROID DEHYDROGENASE-ACTIVITY IN HUMAN LUNG-CELLS ANDTRANSCRIPTION REGULATION BY GLUCOCORTICOIDS, American journal of physiology. Lung cellular and molecular physiology, 11(4), 1994, pp. 120000464-120000474
Citation: N. Page et al., 11-BETA-HYDROXYSTEROID DEHYDROGENASE AND TISSUE-SPECIFICITY OF ANDROGEN ACTION IN HUMAN PROSTATE-CANCER CELL LNCAP, Journal of steroid biochemistry and molecular biology, 49(2-3), 1994, pp. 173-181
Authors:
WARRIAR N
PAGE N
KOUTSILIERIS M
GOVINDAN MV
Citation: N. Warriar et al., ANTIANDROGENS INHIBIT HUMAN ANDROGEN RECEPTOR-DEPENDENT GENE-TRANSCRIPTION ACTIVATION IN THE HUMAN PROSTATE-CANCER CELLS LNCAP, The Prostate, 24(4), 1994, pp. 176-186
Citation: N. Warriar et al., HORMONE-BINDING DOMAIN OF HUMAN GLUCOCORTICOID RECEPTOR - ENHANCEMENTOF TRANSACTIVATION FUNCTION BY SUBSTITUTION MUTANTS M565R AND A573Q, The Journal of biological chemistry, 269(46), 1994, pp. 29010-29015
Citation: N. Warriar et al., SUBSTITUTION OF CYS-560 BY PHE, TRP, TYR, AND SER IN THE FIRST ZINC-FINGER OF HUMAN ANDROGEN RECEPTOR AFFECTS HORMONAL SENSITIVITY AND TRANSCRIPTIONAL ACTIVATION, The Journal of biological chemistry, 269(46), 1994, pp. 29016-29023
Citation: N. Warriar et al., TRANSCRIPTION ACTIVATION OF MOUSE MAMMARY-TUMOR VIRUS-CHLORAMPHENICOLACETYLTRANSFERASE - A MODEL TO STUDY THE METABOLISM OF CORTISOL, Biochemistry, 33(43), 1994, pp. 12837-12843
Citation: N. Warriar et al., TRANSCRIPTION ACTIVATION OF MOUSE MAMMARY-TUMOR VIRUS-CHLORAMPHENICOLACETYLTRANSFERASE - A MODEL TO STUDY THE METABOLISM OF CORTISOL, Biochemistry, 33(43), 1994, pp. 12837-12843
Authors:
LAPOINTE J
BERGERON D
DUFOUR M
DUBE D
GOVINDAN MV
LAMBERT RD
Citation: J. Lapointe et al., BIOCHEMICAL AND MORPHOLOGICAL CHARACTERIZATIONS OF DU-145 CELL MORTALITY IN RABBIT EMBRYO-FETAL FLUID, Cell proliferation, 26(2), 1993, pp. 125-138
Authors:
WARRIAR N
PAGE N
KOUTSILIERIS M
GOVINDAN MV
Citation: N. Warriar et al., INTERACTION OF ANTIANDROGEN-ANDROGEN RECEPTOR COMPLEXES WITH DNA AND TRANSCRIPTION ACTIVATION, Journal of steroid biochemistry and molecular biology, 46(6), 1993, pp. 699-711
Authors:
KOUTSILIERIS M
FRENETTE G
LAZURE C
LEHOUX JG
GOVINDAN MV
POLYCHRONAKOS C
Citation: M. Koutsilieris et al., UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - A PARACRINE FACTOR REGULATING THE BIOAVAILABILITY OF IGFS IN PA-III CELL-INDUCED OSTEOBLASTIC METASTASES, Anticancer research, 13(2), 1993, pp. 481-486